JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CALDWELL, R. W.
Right arrow Articles by GOLDBERG, L. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CALDWELL, R. W.
Right arrow Articles by GOLDBERG, L. I.
Journal of Pharmacology And Experimental Therapeutics, Vol. 172, Issue 2, 297-309, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


AN EVALUATION OF THE VASODILATION PRODUCED BY MEPHENTERMINE AND CERTAIN OTHER SYMPATHOMIMETIC AMINES

R. WILLIAM CALDWELL 1 and LEON I. GOLDBERG 1

1 Department of Pharmacology and the Department of Medicine (Division of Clinical Pharmacology), Emory University, Atlanta, Georgia

Mephentermine injected into femoral, renal or superior mesenteric arteries of pentobarbital-anesthetized dogs increased blood flow in proportion to dose. The effect was not blocked by propranolol, atropine or antihistamine compounds. Vasodilation was also observed with pseudoephedrine, d-amphetamine, methamphetamine, methyiphenidate, Lilly 390 and BW 654. No apparent relationship between structure and vasodilating activity was noted among these amines. Each of these amines also produced secondary vasoconstriction, particularly after phenoxybenzamine or reserpine. Segmental resistance studies in the perfused forelimb of phenoxybenzamine-pretreated dogs showed that the decrease in total resistance produced by mephentermine is due to a reduction in small vessel resistance, as is the case with isoproterenol and glyceryl trinitrate. Mephentermine, unlike the other agents, increased resistance in the arterial segment. Isolated rabbit portal veins showed a dose-related relaxation to mephentermine which was not blocked by MJ-1999 in a dose which blocked the effects of isoproterenol. The demonstration of this vasodilation in these three vascular beds and relaxation of the isolated portal vein suggests that this dilating phenomenon is not selective as to vascular bed.

Submitted on June 27, 1969
Accepted on December 5, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.